Cost Minimisation Analysis: Kilovoltage Imaging with Automated Repositioning Versus Electronic Portal Imaging in Image-guided Radiotherapy for Prostate Cancer

Clinical Oncology

Volumn 24, Issue 8, 2012, Pages

  Gill, S ^a   Younie, S ^b   Rolfo, A ^a   Thomas, J ^a   Siva, S ^a   Fox, C ^a   Kron, T ^a   Phillips, D ^a   Tai, K H ^a,c   Foroudi, F ^a,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cost minimisation analysis; Fiducial markers; IGRT; Prostate cancer; Treatment time

Indexed keywords

ARTICLE; AUTOMATION; CANCER PATIENT; COST CONTROL; COST MINIMIZATION ANALYSIS; ELECTRONIC PORTAL IMAGING; ELECTRONICS; FIDUCIAL MARKER; HEALTH CARE COST; HUMAN; IMAGE GUIDED RADIOTHERAPY; IMAGING; INTERMETHOD COMPARISON; KILOVOLTAGE IMAGING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY ANALYSIS; TREATMENT DURATION;

COSTS AND COST ANALYSIS; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84865997856     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.04.004     Document Type: Article

References (22)

1. Viani G.A., Stefano E.J., Afonso S.L. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 2009, 74:1405-1418.
2. Gauthier I., Carrier J.F., Beliveau-Nadeau D., Fortin B., Taussky D. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment. Int J Radiat Oncol Biol Phys 2009, 74:1128-1133.
3. Jarad M., Andrew B., Robert B., et al. Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol 2009, 4. 10.1186/1748-717X-4-50.
4. Kupelian P.A., Langen K.M., Willoughby T.R., Zeidan O.A., Meeks S.L. Image-guided radiotherapy for localized prostate cancer: treating a moving target. Semin Radiat Oncol 2008, 18(1):58-66.
5. Button M.R., Staffurth J.N. Clinical application of image-guided radiotherapy in bladder and prostate cancer. Clin Oncol (R Coll Radiol) 2010, 22:698-706.
6. Thompson A., Fox C., Foroudi F., et al. Planning and implementing an implanted fiducial programme for prostate cancer radiation therapy. J Med Imaging Radiat Oncol 2008, 52:419-424.
7. Gill S., Thomas J., Fox C., et al. Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol 2011, 6:145.
8. Rimmer Y.L., Burnet N.G., Routsis D.S., et al. Practical issues in the implementation of image-guided radiotherapy for the treatment of prostate cancer within a UK department. Clin Oncol (R Coll Radiol) 2008, 20:22-30.
9. Jaffray D.A., Chawla K., Yu C., Wong J.W. Dual-beam imaging for online verification of radiotherapy field placement. Int J Radiat Oncol Biol Phys 1995, 33:1273-1280.
10. Pisani L., Lockman D., Jaffray D., Yan D., Martinez A., Wong J. Setup error in radiotherapy: on-line correction using electronic kilovoltage and megavoltage radiographs. Int J Radiat Oncol Biol Phys 2000, 47:825.
11. Gill S., Thomas J., Fox C., et al. Electronic portal imaging vs kilovoltage imaging in fiducial marker image guided radiotherapy for prostate cancer: an analysis of set-up uncertainties. Br J Radiol 2012, 85:176-182.
12. Bel A., Petrascu O., Van de Vondel I., et al. A computerized remote table control for fast on-line patient repositioning: implementation and clinical feasibility. Med Phys 2000, 27:354.
13. Jefferies S., Taylor A., Reznek R. Results of a national survey of radiotherapy planning and delivery in the UK in 2007. Clin Oncol (R Coll Radiol) 2009, 21:204-217.
14. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., Stoddart G.L. Methods for the economic evaluation of health care programmes 2005, Oxford University Press, New York.
15. Kron T., Thomas J., Fox C., et al. Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers. Radiother Oncol 2010, 95:191-197.
16. Fox C., Fisher R., Kron T., et al. Extraction of data for margin calculations in prostate radiotherapy from a commercial record and verify system. J Med Imaging Radiat Oncol 2010, 54:161-170.
17. Foroudi F., Lapsley H., Manderson C., Yeghiaian-Alvandi R. Cost-minimization analysis: radiation treatment with and without a multi-leaf collimator. Int J Radiat Oncol Biol Phys 2000, 47:1443-1448.
18. Chung P.W.M., Haycocks T., Brown T., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 2004, 60:329-334.
19. Langen K.M., Willoughby T.R., Meeks S.L., et al. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys 2008, 71:1084-1090.
20. Delaney G.P., Shafiq R.J., Jalaludin B.B., Barton M.B. The development of a new basic treatment equivalent model to assess linear accelerator throughput. Clin Oncol (R Coll Radiol) 2005, 17:311-318.
21. Baume P. cROI. A vision for radiotherapy 2002, Department of Health, Canberra.
22. Lievens Y., Van den Bogaert W., Kesteloot K. Activity-based costing: a practical model for cost calculation in radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57:522-535.